These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36696243)

  • 1. Soluble receptor for advanced glycation end products (sRAGE) correlates with obesity-related parameters, and it is not easy to be modified by moderate caloric restriction in obese humans.
    Kanikowska D; Kanikowska A; Swora-Cwynar E; Grzymisławski M; Sato M; Breborowicz A; Witowski J; Korybalska K
    J Physiol Pharmacol; 2022 Aug; 73(4):. PubMed ID: 36696243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptor for advanced glycation end products as a potential biomarker to predict weight loss and improvement of insulin sensitivity by a very low calorie diet of obese human subjects.
    Hagen I; Schulte DM; Müller N; Martinsen J; Türk K; Hedderich J; Schreiber S; Laudes M
    Cytokine; 2015 Jun; 73(2):265-9. PubMed ID: 25802195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of EN-RAGE, sRAGE, and its isoforms: cRAGE, esRAGE in obese patients treated by moderate caloric restriction combined with physical activity conducted in hospital condition.
    Kanikowska D; Kanikowska A; Strojny Z; Kawka E; Zawada A; Rutkowski R; Litwinowicz M; Sato M; Grzymisławski M; Bręborowicz A; Witowski J; Korybalska K
    Cytokine; 2024 Aug; 180():156665. PubMed ID: 38823153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
    Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
    Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products and their receptors did not show any association with body mass parameters in metabolically healthy adolescents.
    Garay-Sevilla ME; Torres-Graciano S; Villegas-Rodríguez ME; Rivera-Cisneros AE; Wrobel K; Uribarri J
    Acta Paediatr; 2018 Dec; 107(12):2146-2151. PubMed ID: 29846968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation end products and lipid profile ratio as cardiovascular risk markers in children with obesity.
    Flores-Ramírez AG; Ibarra-Reynoso LDR; Garay-Sevilla ME
    Gac Med Mex; 2023; 159(1):10-16. PubMed ID: 36930549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study.
    Tayyib NA; Ramaiah P; Alshahrani SH; Margiana R; Almalki SG; Kareem AK; Zabibah RS; Shbeer AM; Ali SHJ; Mustafa YF
    BMC Endocr Disord; 2023 Dec; 23(1):275. PubMed ID: 38102636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating levels of carboxymethyllysine, soluble receptor for advanced glycation end products (sRAGE), and inflammation markers in women during normal pregnancy.
    Quintanilla-García CV; Uribarri J; Fajardo-Araujo ME; Barrientos-Romero JJ; Romero-Gutiérrez G; Reynaga-Ornelas MG; Garay-Sevilla ME
    J Matern Fetal Neonatal Med; 2019 Dec; 32(24):4102-4107. PubMed ID: 29804482
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women.
    Dozio E; Briganti S; Delnevo A; Vianello E; Ermetici F; Secchi F; Sardanelli F; Morricone L; Malavazos AE; Corsi Romanelli MM
    Eur J Nutr; 2017 Dec; 56(8):2557-2564. PubMed ID: 27522371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inverse association between serum soluble receptor of advanced glycation end products and hyperandrogenism and potential implication in polycystic ovary syndrome patients.
    Liao Y; Huang R; Sun Y; Yue J; Zheng J; Wang L; Tao T; Ma J; Li S; Liu W
    Reprod Biol Endocrinol; 2017 Jan; 15(1):9. PubMed ID: 28125989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Levels of sRAGE Are Associated with Body Measurements, but Not Glycemic Parameters in Patients with Prediabetes.
    Guclu M; Ali A; Eroglu DU; Büyükuysal SO; Cander S; Ocak N
    Metab Syndr Relat Disord; 2016 Feb; 14(1):33-9. PubMed ID: 26569122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased calcium intake from skimmed milk in energy-restricted diets reduces glycation markers in adults with type 2 diabetes and overweight: A secondary analysis of a randomized clinical trial.
    Oliveira JSE; Gomes JMG; Costa JA; Oliveira LL; Alfenas RCG
    Nutr Res; 2024 Jul; 127():40-52. PubMed ID: 38861793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of high sensitivity C-reactive protein by soluble receptor for advanced glycation end products.
    McNair ED; Wells CR; Mabood Qureshi A; Basran R; Pearce C; Orvold J; Devilliers J; Prasad K
    Mol Cell Biochem; 2010 Aug; 341(1-2):135-8. PubMed ID: 20339904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term low calorie diet intervention reduces serum advanced glycation end products in healthy overweight or obese adults.
    Gugliucci A; Kotani K; Taing J; Matsuoka Y; Sano Y; Yoshimura M; Egawa K; Horikawa C; Kitagawa Y; Kiso Y; Kimura S; Sakane N
    Ann Nutr Metab; 2009; 54(3):197-201. PubMed ID: 19420913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects.
    Kim OY; Jo SH; Jang Y; Chae JS; Kim JY; Hyun YJ; Lee JH
    Nutr Res; 2009 Feb; 29(2):106-13. PubMed ID: 19285601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis Patients with Higher Serum Levels of Soluble Receptor for Advanced Glycation End Products Have an Increased Risk for Arteriovenous Fistula Failure.
    Ticala M; Rusu CC; Moldovan D; Potra AR; Tirinescu DC; Coman AL; Bondor CI; Budisan L; Kacsó IM
    Blood Purif; 2022; 51(9):764-771. PubMed ID: 34794141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.